Literature DB >> 1708184

Sequence evidence for RNA recombination in field isolates of avian coronavirus infectious bronchitis virus.

J G Kusters1, E J Jager, H G Niesters, B A van der Zeijst.   

Abstract

Under laboratory conditions coronaviruses were shown to have a high frequency of recombination. In The Netherlands, vaccination against infectious bronchitis virus (IBV) is performed with vaccines that contain several life-attenuated virus strains. These highly effective vaccines may create ideal conditions for recombination, and could therefore be dangerous in the long term. This paper addresses the question of the frequency of recombination of avian coronavirus IBV in the field. A method was sought to detect and quantify recombination from sequence data. Nucleotide sequences of eight IBV isolates in a region of the genome suspected to contain recombination, were aligned and compared. Phylogenetic trees were constructed for different sections of this region. Differences in topology between these trees were observed, suggesting that in three out of eight strains in vivo RNA recombinant had occurred.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1708184      PMCID: PMC7131616          DOI: 10.1016/0264-410x(90)90018-h

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Cloning and sequencing of genes encoding structural proteins of avian infectious bronchitis virus.

Authors:  S Sutou; S Sato; T Okabe; M Nakai; N Sasaki
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

2.  A comprehensive sequence analysis program for the IBM personal computer.

Authors:  C Queen; L J Korn
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

3.  Molecular epidemiology of infectious bronchitis virus in The Netherlands.

Authors:  J G Kusters; H G Niesters; N M Bleumink-Pluym; F G Davelaar; M C Horzinek; B A Van der Zeijst
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

4.  Cloning and sequencing of the gene encoding the spike protein of the coronavirus IBV.

Authors:  M M Binns; M E Boursnell; D Cavanagh; D J Pappin; T D Brown
Journal:  J Gen Virol       Date:  1985-04       Impact factor: 3.891

5.  Coronavirus proteins: biogenesis of avian infectious bronchitis virus virion proteins.

Authors:  D F Stern; B M Sefton
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

6.  Occurrence and significance of infectious bronchitis virus variant strains in egg and broiler production in the Netherlands.

Authors:  F G Davelaar; B Kouwenhoven; A G Burger
Journal:  Vet Q       Date:  1984-07       Impact factor: 3.320

7.  Evolution of avian coronavirus IBV: sequence of the matrix glycoprotein gene and intergenic region of several serotypes.

Authors:  D Cavanagh; P J Davis
Journal:  J Gen Virol       Date:  1988-03       Impact factor: 3.891

8.  Coronavirus IBV: partial amino terminal sequencing of spike polypeptide S2 identifies the sequence Arg-Arg-Phe-Arg-Arg at the cleavage site of the spike precursor propolypeptide of IBV strains Beaudette and M41.

Authors:  D Cavanagh; P J Davis; D J Pappin; M M Binns; M E Boursnell; T D Brown
Journal:  Virus Res       Date:  1986-02       Impact factor: 3.303

9.  The peplomer protein sequence of the M41 strain of coronavirus IBV and its comparison with Beaudette strains.

Authors:  H G Niesters; J A Lenstra; W J Spaan; A J Zijderveld; N M Bleumink-Pluym; F Hong; G J van Scharrenburg; M C Horzinek; B A van der Zeijst
Journal:  Virus Res       Date:  1986-08       Impact factor: 3.303

10.  Evidence for a coiled-coil structure in the spike proteins of coronaviruses.

Authors:  R J de Groot; W Luytjes; M C Horzinek; B A van der Zeijst; W J Spaan; J A Lenstra
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

View more
  64 in total

Review 1.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

2.  The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection.

Authors:  S H Seo; L Wang; R Smith; E W Collisson
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Sequence and phylogenetic analysis of S1, S2, M, and N genes of infectious bronchitis virus isolates from Malaysia.

Authors:  Zarirah M Zulperi; A R Omar; S S Arshad
Journal:  Virus Genes       Date:  2009-02-26       Impact factor: 2.332

4.  Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus.

Authors:  A A Herrewegh; I Smeenk; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Prevalence and genetic pattern of feline coronaviruses in urban cat populations.

Authors:  I Kiss; S Kecskeméti; J Tanyi; B Klingeborn; S Belák
Journal:  Vet J       Date:  2000-01       Impact factor: 2.688

Review 6.  Viral quasispecies.

Authors:  Raul Andino; Esteban Domingo
Journal:  Virology       Date:  2015-03-29       Impact factor: 3.616

7.  Spike gene analysis of the DE072 strain of infectious bronchitis virus: origin and evolution.

Authors:  C W Lee; M W Jackwood
Journal:  Virus Genes       Date:  2001-01       Impact factor: 2.332

8.  Phylogenetic and evolutionary relationships among torovirus field variants: evidence for multiple intertypic recombination events.

Authors:  S L Smits; A Lavazza; K Matiz; M C Horzinek; M P Koopmans; R J de Groot
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Sequence analysis of strains of avian infectious bronchitis coronavirus isolated during the 1960s in the U.K.

Authors:  D Cavanagh; P J Davis
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens.

Authors:  J Ignjatovic; L Galli
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.